Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Intertek Pharmaceutical ServicesIntertek Pharmaceutical Services
VS
MENARINI GroupMENARINI Group
Intertek Pharmaceutical Services

Intertek Pharmaceutical Services

Hexagon Tower, UK | USA | Switzerland | France , M9 8GQ, GB

Last Update: 29/12/2025

View Profile
754/1000Fair

Contract pharmaceutical & biopharmaceutical GLP/GCP/GMP laboratory services, global supply chain GXP auditing services and regulatory guidance supporting drug development and production. Bringing quality and safety to life, we offer Total Quality Assurance expertise to...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:25
12-month incidents
0
Known data breaches
0
Attack type number
0
MENARINI Group

MENARINI Group

Via dei Sette Santi 1/3, Firenze, 50131, IT

Last Update: 12/09/2026

View Profile
Between 750 and 799
https://www.menarini.com
785/1000Fair

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,065
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Intertek Pharmaceutical Services

Intertek Pharmaceutical Services

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MENARINI Group

MENARINI Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Intertek Pharmaceutical Services in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MENARINI Group in 2026.

Incidents

Incident History - Intertek Pharmaceutical Services (X = Date, Y = Severity)

Intertek Pharmaceutical Services cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MENARINI Group (X = Date, Y = Severity)

MENARINI Group cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Intertek Pharmaceutical Services

Intertek Pharmaceutical Services

Incidents
No explicit notable incidents reported.
MENARINI Group

MENARINI Group

Incidents
No explicit notable incidents reported.

FAQ

Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has the best AI Cybersecurity Score ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has experienced more cyber incidents in the past ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has experienced more cyber incidents this year ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has experienced at least one ransomware attack ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has experienced at least one data breach ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has experienced at least one targeted cyberattack ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has experienced at least one vulnerability ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one holds the most compliance certifications ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one holds the fewest compliance certifications ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has the most subsidiaries ?
Between Intertek Pharmaceutical Services company and MENARINI Group company, which one has the largest number of employees ?
Between Intertek Pharmaceutical Services and MENARINI Group, which company holds both SOC 2 Type 1 certifications ?
Between Intertek Pharmaceutical Services and MENARINI Group, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Intertek Pharmaceutical Services or MENARINI Group ?
Which company is PCI DSS compliant - Intertek Pharmaceutical Services or MENARINI Group ?
Between Intertek Pharmaceutical Services and MENARINI Group, which company complies with HIPAA regulations for healthcare data ?
Between Intertek Pharmaceutical Services and MENARINI Group, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-113705
SUMMARY

A vulnerability was determined in a2aproject a2a-rs up to 0.4.3. This issue affects some unknown processing of the file a2a-server/src/error.rs. Executing a manipulation can lead to information exposure through error message. The attack can be executed remotely. This patch is called 713b943af94ab2d521d483b841618b97a2e78a4d. A patch should be applied to remediate this issue.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 5.3)
CVSS2
Base Score: 5.0
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:N/A:N
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-9825
SUMMARY

IBM Cyber Fraud 1.0.0 through 1.0.2 has a missing secure attribute allowing sensitive cookies to be transmitted over unencrypted connections, potentially enabling an attacker to intercept session data through network-based attacks.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-94402
SUMMARY

IBM Carbon Charts 0.4.0 through 1.27.19 is vulnerable to cross-site scripting. The MeterChart component's Title.truncateTitle() function re-inserts a substring of user-supplied label text into the DOM via an unsanitized innerHTML write when the title exceeds the available container width. A remote attacker could exploit this vulnerability to execute arbitrary JavaScript in the victim's browser session.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 6.1)
CVSS3
Base Score: 6.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
IMPACT SCORE
2.7
EXPLOITABILITY
2.8
CVE-2026-93888
SUMMARY

IBM Sterling Connect Direct for Unix 6.4.0.0 through 6.4.0.6 and 6.3.0.0 through 6.3.0.7 apnotify utility is vulnerable to a code injection due to insufficient validation of user input.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-93744
SUMMARY

IBM i 7.3, 7.4, 7.5, and 7.6 could allow an unathenticated remote attacker to bypass security restrictions due to improper access control. By sending a specially crafted HTTP request to any URL within the Navigator application prior to authentication, a bad actor could exploit this vulnerability to alter server-side session security state.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
3.9